GlySure
GlySure develops a continuous intravascular glucose monitoring system using a proprietary optical fluorescence sensor.
GlySure is active in the health care, hospital, sensor space based in Europe, Middle East, and Africa (EMEA), founded in 2003.
GlySure is positioned in health care, hospital, sensor, a segment that rewards a clear, focused offering.
Its base of operations is Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Series_C.
The company reports a headcount in the c_00011_00050 range.
Public records show total funding of about $24.4M.
| Sector | Health Care, Hospital, Sensor |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2003 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $24,414,118 |
Website: www.glysure.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account